Ganghoferstrasse 70 A
80339 München, de
+49 (89) 2189979-73
Nanion celebrates its 10th anniversary - still with a strong focus on new innovation
Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals.
The Port-a-Patch - launched in 2003 - was Nanion’s first product, and is known as the world’s smallest patch clamp rig. It earned great acclaim by making patch clamp accessible to non-experts. The fully automated patch clamp robots, the Patchliner (2006) and SyncroPatch 96 (2010), have been well received within the pharmaceutical industry because of the high data quality, cost-efficiency and experimental flexibility offered. The platforms are also employed for top-notch academic research, resulting in publications in journals such as Nature, Nature Protocol, Science Signalling and PNAS.
Nanion is a strongly innovation-driven company with several product launches planned for 2012.
Dr. Niels Fertig, co-founder and CEO of Nanion, says:
“Nanion’s strong and sustained growth is based on innovative technology, high performance instrumentation and close customer relations. It has been a really exciting journey gradually turning from start-up into a more mature company with everything that it entails. We are extremely happy about, thankful for and proud of what we have achieved so far and very much look forward to the next decade of product development, science and business growth!”
Michael George, CTO and co-owner of Nanion Technologies continues:
“2012 will be a thrilling year, with several different new products in the pipeline. At Nanion, innovation never ends. This is true as much for brand new ideas and concepts as for existing products. Our customers continue to inspire us to develop hardware and software allowing novel experimental possibilities or just making life easier for the every-day-user. It is very rewarding to get the feedback that we are developing state-of-the-art products enabling completely new strategies for ion channel screening and research.”
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.